# Tatiana Fofanova

> Tatiana Fofanova is the co-founder and CEO of Koda Health, a Houston-based B2B enterprise SaaS company that helps health systems and payers scale advance care planning. Trained as a molecular-medicine PhD at Baylor College of Medicine and a former HHMI scholar, she left bench and pediatric work after concluding that patients needed access and good information more than newer drugs. She built Koda out of the Texas Medical Center's Biodesign Fellowship in 2020 with co-founders Desh Mohan and Katelin Cherry, describing the product as 'TurboTax meets Duolingo' for the hardest conversations in medicine. The company now supports more than a million patients nationwide and raised an oversubscribed $7M Series A in October 2025.

- **Role:** Co-Founder & CEO at Koda Health
- **Organizations:** Koda Health, Texas Medical Center Biodesign, Techstars, Baylor College of Medicine
- **Nationality:** American (immigrated to the U.S. as a child)
- **Education:** PhD in Molecular Medicine (HHMI Scholar), Baylor College of Medicine
- **Known for:** Co-founded and scaled Koda Health to support more than 1 million patients nationwide, Raised an oversubscribed $7M Series A in October 2025 (led by Evidenced); ~$20.4M total funding, Received the 2023 Red Club x Cartier Young Leader Award for advancing healthcare access and inclusivity

## Career timeline

- **pre-2019** — Worked in molecular medicine research and pediatrics; educator and advocate for refugee, unhoused, and seriously ill communities
- **2019** — Accepted into the Texas Medical Center Biodesign Fellowship in Houston
- **2020** — Co-founded Koda Health with Dr. Desh Mohan (CMO) and Katelin Cherry (CTO); accepted into Techstars
- **2022** — Raised $3.5M seed round; grew to 12 full-time employees; launched Spanish-language beta; operating in 25 states
- **2023** — Received the Red Club x Cartier Young Leader Award (runner-up, €10,000 grant); announced Cigna partnership for Medicare Advantage beneficiaries
- **2024** — Launched Kidney Action Planning product with a major Houston health system
- **2025** — Closed oversubscribed $7M Series A led by Evidenced; surpassed 1M+ patients supported nationwide
- **2026** — Secured strategic investment from UPMC Enterprises for its AI-enhanced advance care planning platform

## Achievements

- Co-founded and scaled Koda Health to support more than 1 million patients nationwide
- Raised an oversubscribed $7M Series A in October 2025 (led by Evidenced); ~$20.4M total funding
- Received the 2023 Red Club x Cartier Young Leader Award for advancing healthcare access and inclusivity
- Earned a PhD in Molecular Medicine from Baylor College of Medicine as an HHMI Scholar
- Built partnerships with Cigna, Privia, Memorial Hermann, and Guidehealth
- Secured strategic investment from UPMC Enterprises (2026)

## Latest updates

- **2026-04** — Koda Health secured a strategic investment from UPMC Enterprises for its AI-enhanced advance care planning platform.
- **2025-10** — Closed an oversubscribed $7M Series A led by Evidenced; surpassed 1M+ patients supported nationwide with plans for two new product lines.

## Links

- Website: https://kodahealthcare.com
- LinkedIn: http://www.linkedin.com/in/fofanova
- Twitter/X: https://twitter.com/kodahealth
- YouTube: https://www.youtube.com/watch?v=UmXwgLk_Oec

---

Profile page: https://yespress.io/tatiana-fofanova
Published by YesPress — https://yespress.io
Last updated: 2026-07-08